ConductScience.org, home

Paper9645271

A rational basis for the use of combined heparin/aspirin and IVIG immunotherapy in the treatment of recurrent IVF failure associated with antiphospholipid antibodies.

Sher G and 6 others. Am J Reprod Immunol, 1998. Cited by 50 papers, by iCite.

Cite this record

ConductScience Library. A rational basis for the use of combined heparin/aspirin and IVIG immunotherapy in the treatment of recurrent IVF failure associated with antiphospholipid antibodies. Papers, record 9645271. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9645271

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A rational basis for the use of combined heparin/aspirin and IVIG immunotherapy in the treatment of recurrent IVF failure associated with antiphospholipid antibodies.
PubMed
Journal
Am J Reprod Immunol
PubMed
Year
1998
PubMed
Publication types
Clinical Trial, Journal Article
PubMed
Citations, by iCite
50
iCite
Relative citation ratio, by iCite
1.87
iCite
Revised in PubMed
2022-04-09
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sher GG
2Zouves CC
3Feinman MM
4Maassarani GG
5Matzner WW
6Chong PP
7Ching WW

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, AntiphospholipidMajor topic
AspirinMajor topic
HeparinMajor topic
Immunoglobulins, IntravenousMajor topic
Infertility, FemaleMajor topic
Adult
Combined Modality Therapy
Drug Therapy, Combination
Female
Fertilization in Vitro
Humans
Immunotherapy
Male
Pregnancy
Treatment Failure

Source PubMed

Download CSV of topics

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 50 citations.

PMIDTitleJournalYearIn PapersSource
36361577Endometrium Immunomodulation to Prevent Recurrent Implantation Failure in Assisted Reproductive Technology.Int J Mol Sci2022https://conductscience.org/library/papers/36361577PubMed
31431993An observational multicentre study on the efficacy and safety of assisted reproductive technologies in women with rheumatic diseases.Rheumatol Adv Pract2019https://conductscience.org/library/papers/31431993PubMed
26318458Pemphigus and pregnancy. Analysis and summary of case reports over 49 years.Saudi Med J2015https://conductscience.org/library/papers/26318458PubMed
25473625Recurrent implantation failure: the role of the endometrium.J Reprod Infertil2014https://conductscience.org/library/papers/25473625PubMed
24693540Evaluation of granulocyte colony-stimulating factor effects on treatment-resistant thin endometrium in women undergoing in vitro fertilization.Biomed Res Int2014https://conductscience.org/library/papers/24693540PubMed
16391398Intravenous immunoglobulin therapy in antiphospholipid syndrome.Clin Rev Allergy Immunol2005https://conductscience.org/library/papers/16391398PubMed
15927049Low-dose aspirin does not improve ovarian stimulation, endometrial response, or pregnancy rates for in vitro fertilization.J Exp Clin Assist Reprod2005https://conductscience.org/library/papers/15927049PubMed
15494069First successful case of in vitro fertilization-embryo transfer with venom immunotherapy for hymenoptera sting allergy.Clin Mol Allergy2004https://conductscience.org/library/papers/15494069PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9645271

GET https://conductscience.org/api/papers/v1/9645271/authors